Lyomark Pharma and InfectoPharm sign exclusive sales and distribution agreement for Alveofact® in Germany
OBERHACHING / HEPPENHEIM – 21 February 2020 – Lyomark Pharma GmbH, the German manufacturer of Alveofact®, and InfectoPharm Arzneimittel und Consilium GmbH, today announced that they have entered into an exclusive agreement for distribution of Alveofact® in Germany. Based on this agreement, InfectoPharm will be the exclusive distributor of Alveofact® on the German market. Specialising … Read more